Modified human plasma polypeptide or Fc scaffolds and their uses

Details for Australian Patent Application No. 2012203737 (hide)

Owner Ambrx, Inc.

Inventors Sheffer, Joseph; Norman, Thea; Dimarchi, Richard D.; Putnam, Anna-maria A. Hays; Feng, Tian; Chu, Stephanie; Krawitz, Denise; Cho, Ho Sung

Agent FB Rice

Pub. Number AU-A-2012203737

Parent 2007292903

Filing date 26 June 2012

Wipo publication date 19 July 2012

International Classifications

C07K 14/435 Peptides having more than 20 amino acids - from animals

C07K 14/765 Peptides having more than 20 amino acids

C07K 16/42 Immunoglobulins, e.g. monoclonal or polyclonal antibodies - against immunoglobulins (anti-idiotypic antibodies)

C07K 16/46 Immunoglobulins, e.g. monoclonal or polyclonal antibodies - Hybrid immunoglobulins

Event Publications

12 July 2012 Complete Application Filed

19 July 2012 Application Open to Public Inspection

  Published as AU-A-2012203737

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2012203738-Modular Cell System for Generating HHO Gas by Electrolysis of a Liquid for Fuel Saving and Exhaust Emission Reduction on Internal Combustion Engines

2012203736-Non-axial return spring for safety needle